APAC Bio Logistics Tracker
Overview
Explore insightful data on the logistical and supply chain aspects of Biopharma, CMOs in the Asia Pacific region. The tracker provides extensive researched based information focused on logistics for vaccines, cell therapy, gene therapy and other biologics.
The data is captured based on around 20 parameters such as Company Name, Country, Facility Establishment Year, Biopharma Product Pipeline, CMO’s Service Offerings, Logistics Requirements, Delivery Routes, Technology Platform, Mode of Operations, Vials/banks for the final drug product, Preferred Delivery Device, Temperature requirements (percentage of the collection at each temperature), Countries in Focus, Routes, 3PLs, Regulatory Approval/Status, Quality Assurance & Quality Management, Key decision makers list for Logistics/SCM.
The tracker is underpinned by user-friendly features to allow users to filter through within all the parameters to obtain any specific data for biologics supply chain for example companies, country, delivery device, manufacturing scale, temperature requirements, regulatory approvals, service offerings among other useful filters.
Pick the right plan!
From evolving customer expectations and emerging technologies to more nimble companies entering industries, businesses today are more at risk for disruption than ever before.
6 Months
$3,640
- Access for 6 months
- Single user
- Monthly Updates
1 Year
$6,530
- Access for 1 year
- Single User
- Monthly Updates
Key Parameters
- Company
- Company Profile
- Location
- Product Focus
- Scale of Operation
- Facility Highlights
- Bioprocessing Capabilities & Processes
- Capacity Details
- Platform Technology
- Drug Product Highlights
- Drug Storage
- Drug Product Delivery Device
- Drug Product Temperature Requirements
- Countries in Focus
- Routes
- 3PL Details
- Product Regulatory Approval
- Logistics
- Logistical Requirements & Updates
Regions Coverage
China, India, Australia, Bangladesh, Indonesia, Korea, Japan, Malaysia, New Zealand, Singapore, Taiwan, Thailand, Vietnam
Product Types Covered
Cell Therapy
Gene Therapy
Vaccines
How This Tracker Will Benefit?
This tracker provides easy to comprehend data for over Biopharma and CMOs in terms of supply chain management and logistics of biologics including vaccines. It has analytical outlook of their service offerings and logistics capabilities to provide you unique insights into biopharma logistics market.
From a logistics perspective, biomedical drugs are considered very time-and-temperature sensitive. Even slight temperatures changes can alter their molecular structure rendering them ineffective or even toxic. This stringent temperature requirement is shared by vaccines, including the Covid-19 vaccine. Such requirements of companies to maintain temperature and storage of biologics are included in this tracker.
Also, the Asia biopharma logistics market is highly competitive and is fragmented with presence of many players. With this tracker you can access the competitive landscape in terms of markets, and APAC geographies to understand supply chain capabilities of companies.
Through this tracker, you are more likely to stay ahead of your competitors by keeping updated track of biopharma players and expand your knowledge & expertise in the APAC logistics market. We ensure the delivery of highly-qualified research as we tap into our database of 62000+ life science professionals curated over a decade.
Data Methodology
The data in this tracker is researched and validated using primary and secondary research. The data is collected through multiple scientific and non-scientific sources including live discussions with experts through IMAPAC’s events and research reports, survey polls, company websites, press releases, publicly available information, regulatory database and many more.
We have a database of key decision makers from the biopharma companies across the region. We host industry surveys with bioprocessing leaders of CMOs and Biopharma, and host primary interviews with Heads of Manufacturing, R&D, Process Development Heads and multiple stakeholders in the companies to gather data as well as validate that data using our primary research analysts.
Throughout the year, we keep in touch with the KOLs through telephonic Conversation, with Q&A sessions with high profile biopharma professionals, for example CSO/CTO profiles. Apart from telephonic conversations, we send a list of questions which these experts fill in detail and send back to us.
We have dedicated analysts who gather data. The data included in the tracker is validated through primary research (interviews, phone calls) with stakeholders which is then validated by IMAPAC’s research analysts to ensure the accuracy of the data.
Key Questions Answered
- What are the regulatory frameworks in the APAC biopharma logistics market?
- What is the volume of temperature sensitive biologics and vaccines moving through APAC supply chains? Is there sufficient air and ocean freight capacity to support this?
- What is the size of logistics departments in biopharma companies and vaccine makers and how much budget do they hold?
- How are Biopharma and CMOs managing their supply chain process?
- What are the modes of transportation for cell and gene therapy products?
- Highlights into vaccine storage and handling
- Which country has the key logistics players supporting biopharma companies?
- What are the various capabilities of the biopharma companies in all regions?
- How many companies in the biopharma industry supports logistics for vaccines, antibodies and CGT products?
Data Sample
